Virginia legislation · 2026 Regular Session
Virginia HB392: An Act to amend and reenact § 32.1-68 of the Code of Virginia, relating to sickle cell disease education and screening program; cancer risk.
Status: Chaptered, April 13, 2026
Sickle cell disease education and screening program; cancer risk. Requires the sickle cell screening and treatment program to include the offering of educational resources to health care providers on the increased risks for certain cancers among individuals with sickle cell disease or the sickle cell trait.
What the bill says
An Act to amend and reenact § 32.1-68 of the Code of Virginia, relating to sickle cell disease education and screening program; cancer risk. [H 392] Approved April 13, 2026 1. That § 32.1-68 of the Code of Virginia is amended and reenacted as review by Board; program to include education and post-screening counseling; laboratory tests. A. The Commissioner, in cooperation with local health directors, shall establish a voluntary program for the screening of adults and children for the disease of sickle cell anemia or the sickle cell trait and for such other genetically related diseases and genet.
From the enrolled text, April 13, 2026:
An Act to amend and reenact § 32.1-68 of the Code of Virginia, relating to sickle cell disease education and screening program; cancer risk. [H 392] Approved April 13, 2026 1. That § 32.1-68 of the Code of Virginia is amended and reenacted as review by Board; program to include education and post-screening counseling; laboratory tests. A. The Commissioner, in cooperation with local health directors, shall establish a voluntary program for the screening of adults and children for the disease of sickle cell anemia or the sickle cell trait and for such other genetically related diseases and genetic traits and inborn errors of metabolism as the Board may deem necessary. B. The Board shall review the program from time to time to determine the appropriate age and the method of screening for such conditions or traits in the light of technological changes. C. The screening program shall include provisions for education concerning the nature and treatment of sickle cell anemia, other genetically related diseases and inborn errors of metabolism and a post-screening counseling program for the treatment of any person determined to have such a condition. Such education shall also address cancers known to be more common in individuals with sickle cell disease or the sickle cell trait, including certain types of kidney cancer. D. The program may include the …